| Period Ending: |
LTM
(Last Twelve Months) |
2025 01-31 |
2024 01-31 |
2023 01-31 |
2022 01-31 |
2021 01-31 |
2020 01-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-12-09 | 2025-03-25 | 2024-03-26 | 2023-03-21 | 2022-03-30 | 2021-01-31 | 2020-01-31 |
| Revenue | 1,521 | 1,249 | 937.4 | 652.5 | 428.3 | 249.9 | 119.9 |
| Cost of Revenue | 350.9 | 298.3 | 247 | 182.7 | 124.5 | 75.39 | 48.32 |
| Gross Profit | 1,170 | 950.9 | 690.4 | 469.9 | 303.9 | 174.5 | 71.54 |
| Operating Expenses | 1,248 | 1,141 | 940.3 | 728.3 | 656.2 | 377.2 | 299.4 |
| Research & Development | 328.4 | 299.7 | 258.6 | 187.4 | 205.1 | 99.74 | 70.47 |
| Selling, General and Administrative | 920.1 | 836.3 | 681.7 | 540.9 | 451.1 | 277.5 | 228.9 |
| Other Operating Expenses | 0 | 4.88 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -78.74 | -190 | -249.9 | -258.4 | -352.3 | -202.7 | -227.8 |
| Net Non-Operating Interest | 24.15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 24.15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 19.34 | 39.56 | -33.46 | 14.56 | -1.53 | -7.41 | 2.93 |
| Income Before Tax | -35.25 | -150.4 | -283.4 | -243.8 | -353.9 | -210.1 | -224.9 |
| Income Tax Expense | 7.11 | 4.49 | 3.34 | 3.59 | 1.17 | 0.087 | 0.34 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -42.36 | -154.9 | -286.7 | -247.4 | -355 | -210.2 | -225.2 |
| Depreciation and Amortization | 41.38 | 20.65 | 112.3 | 76.74 | 49.46 | 37.11 | 24.8 |
| EBITDA | -37.36 | -169.3 | -137.6 | -181.7 | -302.9 | -165.6 | -203 |
| Earnings Per Share (EPS) | -0.075 | -0.28 | -0.54 | -0.48 | -0.7 | -0.42 | -0.45 |
| Diluted Earnings Per Share | -0.078 | -0.28 | -0.54 | -0.48 | -0.7 | -0.42 | -0.45 |
| Weighted Average Shares Outstanding | 571.7 | 556.3 | 534.9 | 514.3 | 505.5 | 500.4 | 500.4 |
| Diluted Weighted Average Shares Outstanding | 571.7 | 556.3 | 534.9 | 514.3 | 505.5 | 500.4 | 500.4 |
